According to the absence or presence of HER2, estrogen receptor (ER) and progesterone receptor (PR), the molecular classification of breast tumors can be luminal A, luminal B, HER2+ enriched cells and triple negative BC. This evidence concerns the gene ERBB2 and breast cancer.